These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 2433788

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A comparison of pentosan polysulphate and heparin. II: Effects of subcutaneous injection.
    Fischer AM, Merton RE, Marsh NA, Williams S, Gaffney PJ, Barrowcliffe TW, Thomas DP.
    Thromb Haemost; 1982 Apr 30; 47(2):109-13. PubMed ID: 6179183
    [Abstract] [Full Text] [Related]

  • 3. Metabolism of sodium pentosan polysulphate in man measured by a new competitive binding assay for sulphated polysaccharides--comparison with effects upon anticoagulant activity, lipolysis and platelet alpha-granule proteins.
    MacGregor IR, Dawes J, Pepper DS, Prowse CV, Stocks J.
    Thromb Haemost; 1985 Jun 24; 53(3):411-4. PubMed ID: 2413564
    [Abstract] [Full Text] [Related]

  • 4. Relationship between biological activity and concentration of a low-molecular-weight heparin (PK 10169) and unfractionated heparin after intravenous and subcutaneous administration.
    Dawes J, Bara L, Billaud E, Samama M.
    Haemostasis; 1986 Jun 24; 16(2):116-22. PubMed ID: 3710290
    [Abstract] [Full Text] [Related]

  • 5. A comparison of pentosan polysulphate (SP54) and heparin. I: Mechanism of action on blood coagulation.
    Fischer AM, Barrowcliffe TW, Thomas DP.
    Thromb Haemost; 1982 Apr 30; 47(2):104-8. PubMed ID: 6179182
    [Abstract] [Full Text] [Related]

  • 6. Effect of pentosan polysulphate administration in man on the formation of covalent complexes between heparin cofactor II and thrombin generated in plasma by contact activation.
    Dol F, Sié P, Dupouy D, Boneu B.
    Thromb Haemost; 1986 Dec 15; 56(3):295-8. PubMed ID: 2436330
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Tolerance and biological activity of pentosan polysulfate after intramuscular or subcutaneous administration for ten days in human volunteers.
    Sié P, Albarede JL, Robert M, Bouloux C, Lansen J, Chigot C, Correll S, Thouvenot JP, Boneu B.
    Thromb Haemost; 1986 Feb 28; 55(1):86-9. PubMed ID: 2422778
    [Abstract] [Full Text] [Related]

  • 10. Absence of transplacental passage of pentosan polysulfate during mid trimester of pregnancy.
    Forestier F, Fischer AM, Daffos F, Beguin S, Diner H.
    Thromb Haemost; 1986 Dec 15; 56(3):247-9. PubMed ID: 2436327
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison between the effect of pentosan polysulphate heparin and antithrombin III injections in antithrombin III deficient patients.
    Fischer AM, Dautzenberg MD, Aurousseau MH, Béguin S, Goudemand J, Hemker HC.
    Thromb Res; 1985 Jan 15; 37(2):295-307. PubMed ID: 2579452
    [Abstract] [Full Text] [Related]

  • 14. Anticoagulant effects of two types of low molecular weight heparin administered subcutaneously.
    Bergqvist D, Hedner U, Sjörin E, Holmer E.
    Thromb Res; 1983 Nov 15; 32(4):381-91. PubMed ID: 6658720
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Highly variable anticoagulant response after subcutaneous administration of high-dose (12,500 IU) heparin in patients with myocardial infarction and healthy volunteers.
    Kroon C, ten Hove WR, de Boer A, Kroon JM, van der Pol JM, Harthoorn-Lasthuizen EJ, Schoemaker HC, van der Meer FJ, Cohen AF.
    Circulation; 1992 Nov 15; 86(5):1370-5. PubMed ID: 1423948
    [Abstract] [Full Text] [Related]

  • 19. The measurement of heparin and other therapeutic sulphated polysaccharides in plasma, serum and urine.
    Dawes J, Prowse CV, Pepper DS.
    Thromb Haemost; 1985 Oct 30; 54(3):630-4. PubMed ID: 2935965
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.